311 related articles for article (PubMed ID: 12368338)
21. Cellular immediate-early gene expression occurs kinetically upstream of Epstein-Barr virus bzlf1 and brlf1 following cross-linking of the B cell antigen receptor in the Akata Burkitt lymphoma cell line.
Ye J; Gradoville L; Miller G
J Virol; 2010 Dec; 84(23):12405-18. PubMed ID: 20861250
[TBL] [Abstract][Full Text] [Related]
22. The BRRF1 early gene of Epstein-Barr virus encodes a transcription factor that enhances induction of lytic infection by BRLF1.
Hong GK; Delecluse HJ; Gruffat H; Morrison TE; Feng WH; Sergeant A; Kenney SC
J Virol; 2004 May; 78(10):4983-92. PubMed ID: 15113878
[TBL] [Abstract][Full Text] [Related]
23. Radiation-induced Epstein-Barr virus reactivation in gastric cancer cells with latent EBV infection.
Nandakumar A; Uwatoko F; Yamamoto M; Tomita K; Majima HJ; Akiba S; Koriyama C
Tumour Biol; 2017 Jul; 39(7):1010428317717718. PubMed ID: 28675108
[TBL] [Abstract][Full Text] [Related]
24. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
Ye J; Gradoville L; Daigle D; Miller G
J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
[TBL] [Abstract][Full Text] [Related]
25. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE
J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases.
Adamson AL; Darr D; Holley-Guthrie E; Johnson RA; Mauser A; Swenson J; Kenney S
J Virol; 2000 Feb; 74(3):1224-33. PubMed ID: 10627532
[TBL] [Abstract][Full Text] [Related]
27. Sequence variation of Epstein-Barr virus (EBV) BZLF1 gene in EBV-associated gastric carcinomas and nasopharyngeal carcinomas in Northern China.
Luo B; Tang X; Jia Y; Wang Y; Chao Y; Zhao C
Microbes Infect; 2011 Aug; 13(8-9):776-82. PubMed ID: 21527354
[TBL] [Abstract][Full Text] [Related]
28. The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 induction.
Swenson JJ; Mauser AE; Kaufmann WK; Kenney SC
J Virol; 1999 Aug; 73(8):6540-50. PubMed ID: 10400750
[TBL] [Abstract][Full Text] [Related]
29. The Epstein-Barr virus immediate-early protein BZLF1 induces expression of E2F-1 and other proteins involved in cell cycle progression in primary keratinocytes and gastric carcinoma cells.
Mauser A; Holley-Guthrie E; Zanation A; Yarborough W; Kaufmann W; Klingelhutz A; Seaman WT; Kenney S
J Virol; 2002 Dec; 76(24):12543-52. PubMed ID: 12438580
[TBL] [Abstract][Full Text] [Related]
30. Sequence analysis of EBV immediate-early gene BZLF1 and BRLF1 in lymphomas.
Yang Y; Jia Y; Wang Y; Wang X; Sun Z; Luo B
J Med Virol; 2014 Oct; 86(10):1788-95. PubMed ID: 24615673
[TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway.
Fahmi H; Cochet C; Hmama Z; Opolon P; Joab I
J Virol; 2000 Jul; 74(13):5810-8. PubMed ID: 10846060
[TBL] [Abstract][Full Text] [Related]
32. [Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma].
Wang Y; Luo B; Zhao P; Huang BH
Ai Zheng; 2004 Jul; 23(7):782-7. PubMed ID: 15248912
[TBL] [Abstract][Full Text] [Related]
33. Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus.
Gutiérrez MI; Ibrahim MM; Dale JK; Greiner TC; Straus SE; Bhatia K
J Natl Cancer Inst; 2002 Dec; 94(23):1757-63. PubMed ID: 12464647
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism.
Zalani S; Holley-Guthrie E; Kenney S
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9194-9. PubMed ID: 8799177
[TBL] [Abstract][Full Text] [Related]
35. Role of the epstein-barr virus RTA protein in activation of distinct classes of viral lytic cycle genes.
Ragoczy T; Miller G
J Virol; 1999 Dec; 73(12):9858-66. PubMed ID: 10559298
[TBL] [Abstract][Full Text] [Related]
36. Strain variation in Epstein-Barr virus immediate early genes.
Packham G; Brimmell M; Cook D; Sinclair AJ; Farrell PJ
Virology; 1993 Feb; 192(2):541-50. PubMed ID: 8093650
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr Virus MicroRNA miR-BART20-5p Suppresses Lytic Induction by Inhibiting BAD-Mediated caspase-3-Dependent Apoptosis.
Kim H; Choi H; Lee SK
J Virol; 2016 Feb; 90(3):1359-68. PubMed ID: 26581978
[TBL] [Abstract][Full Text] [Related]
38. EBV-immortalized isogenic human B-cell clones exhibit differences in DNA-protein complex formation on the BZLF1 and BRLF1 promoter regions among latent, lytic and TPA-activated cell lines.
Cen H; McKnight JL
Virus Res; 1994 Jan; 31(1):89-107. PubMed ID: 8165871
[TBL] [Abstract][Full Text] [Related]
39. Elevation of antibody against Epstein-Barr virus genes BRLF1 and BZLF1 in nasopharyngeal carcinoma.
Yoshizaki T; Miwa H; Takeshita H; Sato H; Furukawa M
J Cancer Res Clin Oncol; 2000 Feb; 126(2):69-73. PubMed ID: 10664244
[TBL] [Abstract][Full Text] [Related]
40. Ceramide promotes lytic reactivation of Epstein-Barr virus in gastric carcinoma.
Kim JY; Min YJ; Lee M-H; An YR; Ashktorab H; Smoot DT; Kwon SW; Lee SK
J Virol; 2024 Feb; 98(2):e0177623. PubMed ID: 38197630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
